BCOR and myelodysplastic syndrome: BCOR, a gene involved in epigenetic regulation, is frequently inactivated in hematologic malignancies such as acute myeloid leukemia and myelodysplastic syndromes, and its mutations are often associated with poor prognosis (17, 18).